Table 4.
Adjusted Rates of Symptoms in Patients
N=5422 | Any Symptom | Any Moderate to Severe Symptom | ||
---|---|---|---|---|
Adjusted Proportions for Patients with Any Symptoms | P-value | Adjusted Proportions for Patients with Any Moderate to Severe Symptoms | P-value | |
Gender | ||||
Male (reference) | 92.7% | 47.2% | ||
Female | 94.3% | 0.02 | 54.7% | <0.001 |
Age (yrs) | ||||
21–59 | 95.3% | 0.31 | 57.7% | <0.001 |
60–69 | 92.5% | 0.17 | 49.3% | 0.04 |
70–79 | 91.7% | 0.03 | 45.7% | 0.61 |
80+ (reference) | 94.2% | 44.6% | ||
Race | ||||
White (reference) | 93.4% | 51.1% | ||
Hispanic or Latino | 93.4% | 0.97 | 56.2% | 0.04 |
African American | 93.9% | 0.61 | 48.5% | 0.17 |
Other | 93.3% | 0.93 | 47.5% | 0.09 |
Education | ||||
College degree or more (reference) | 92.6% | 48.2% | ||
High school/some college | 93.8% | 0.12 | 51.4% | 0.04 |
Less than high school | 93.9% | 0.23 | 52.3% | 0.05 |
Insurance status | ||||
Private (reference) | 93.4% | 48.3% | ||
VA | 93.4% | 0.95 | 58.3% | <0.001 |
Supplemental | 93.6% | 0.90 | 50.3% | 0.31 |
Public | 92.4% | 0.41 | 53.0% | 0.05 |
None | 96.4% | 0.16 | 48.4% | 0.99 |
Wealth (how much money saved to live at current cost of living) | ||||
More than one year (reference) | 91.9% | 46.2% | ||
7–12 months | 95.4% | 0.03 | 50.5% | 0.10 |
3–6 months | 94.4% | 0.06 | 51.0% | 0.04 |
1–2 months | 95.1% | 0.03 | 56.2% | <0.001 |
< 1 month | 95.3% | 0.001 | 56.9% | <0.001 |
Marital Status | ||||
Not married (reference) | 94.0% | 53.2% | ||
Married | 93.1% | 0.23 | 49.0% | 0.001 |
Cancer Type | ||||
Colorectal (reference) | 90.2% | 38.5% | ||
Lung | 98.2% | <0.001 | 66.3% | <0.001 |
Stage | ||||
Early (reference) | 93.4% | 49.6% | ||
Late | 93.6% | 0.85 | 53.3% | 0.01 |
Surgery in last 6 weeks | ||||
Not received (reference) | 93.3% | 50.0% | ||
Received | 96.2% | 0.05 | 65.6% | <0.001 |
Radiation in last 6 weeks | ||||
Not received (reference) | 93.3% | 49.5% | ||
Received | 96.2% | 0.08 | 61.0% | <0.001 |
Chemotherapy in last 6 weeks | ||||
Not received (reference) | 90.8% | 46.2% | ||
Received | 97.3% | <0.001 | 56.8% | <0.001 |
Comorbidity | ||||
0–1 | 92.0% | 44.5% | ||
2+ | 95.9% | <0.001 | 60.4% | <0.001 |